AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2578-8965/028
Obstetrics and Gynecology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
*Corresponding Author: Hend S Saleh, Obstetrics and Gynecology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt: E-mail: drhendsaleh@yahoo.com
Citation: Hend S Saleh, Hala E Sherif and Eman M Mahfouz. (2019) Single Dose of Methotrexate Therapy Followed By Suction Curettage for Management of Cesarean Scar Pregnancy. Obstetrics Gynecology and Reproductive Sciences, 3(1): DOI: 10.31579/2578-8965/028
Copyright: © 2019. Hend S Saleh. This is an open-access article distributed under the termsof the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Received: 06 November 2019 | Accepted: 16 November 2019 | Published: 02 December 2019
Keywords: ectopic pregnancy; cesarean section; scar; curettage ; MTX treatment
Objective
Implantation of the pregnancy in a cesarean scar is a rare condition named ; Cesarean scar pregnancy (CSP). Maternal complications can be prevented with the early diagnosis and an appropriate management .It is a Prospective clinical study to evaluate the efficacy and success rate of single dose use of methotrexate (MTX) followed by dilation and suction (D&S) regimen in management of women with cesarean scar pregnancy (CSP).
Methods
50mg of MTX in the form of a single dose Intramuscular injection then cervical dilatation and suction aspiration with a Karman cannula(D&S) under guidance of ultrasound after 48 preeceeded by vaginal misoprostol 2 tablet (200 mg) 4 hours ago.
Results
The mean gestational age at diagnosis was (8.5±1.6 ) and The mean level of serum b-human chorionic gonadotropin was (7424±2.560 ) and The mean gestational age of pregnancy was (8.5±1.6 ) .88.7% is the successive rate without complication need intervention, 2 (5.7%) patients needed intrauterine Foley's catheter for 24 hours as a mechanical hemostasis . 2 (5.7 %) had laparotomy with wedge resection of the gestational sac lesion and successful repair of the uterine defect and one (2.8 %)underwent subtotal hysterectomy.
Conclusion: Systemic single dose MTX injection followed by D&S is an effective and harmless management for CSP. Nevertheless more studies are required to prove the efficiency, safety, and reproductive outcome of variant modalities in treatment of CSP.
Increase the incidence caesarean delivery lead to attendance of one serious complication which is Cesarean scar pregnancy (CSP) is a uncommon form of ectopic pregnancy in which the gestational sac is imbedded in a cesarean scar of the lower uterine segment.[ 1]CSP is a risky condition, probably leading to immense bleeding uterine rupture,and life-threatening complications[2].The accurate incidence of CSP is unidentified. It is presently valued at 1:1800-2200 pregnancies. It exemplifies 6.1% of whole ectopic pregnancies with a history of at least one previous caesarean Section [ ,3 ]
The etiology and pathophysiology of CSP is still unidentified , may be related to an standing scar defect or microscopic dehiscent tract created between the previous cesarean scar tissue and the endometrial canal [4]. In the early days of pregnancy the blastocyst invades the myometrium via a microscopic abrasion present in the cesarean scar linked to a preceding uterine trauma such as cesarean section, metroplasty, myomectomy, and may be the manual elimination of the placenta. Some authors revealed its potential association to intrauterine Device and pelvic Inflammatory disease [5]. The most common symptom is painless vaginal bleeding that may be massive. There is no definite clinical sign of CSP.
Clinical history, serial serum human chorionic gonadotropin (HCG) measurements and transvaginal ultrasound examination, mainly in pregnant woman with a previous cesarean delivery early in pregnancy are necessary for early diagnosis and termination of that pregnancy .[6] Also magnetic resonance imaging (MRI), and endoscopic modalities may be helpful for diagnosis and the management of(CSP). It is frequently required for cases in which the TVUS is not definite or did not obviously prove urinary bladder Envelopment [ 7] To decrease the threat of a false diagnosis and improve its accuracy, a collective ultrasound ( TVS, TAS, color flow Doppler, and three-dimensional TVS ) should be suggested [ 8]The modalities of treatment are whichever medical , surgical or combined .There is no agreement on the favorite mode of management. Medical protocol Includes systemic ( single or repeated doses) or local administration of methotrexate (MTX),potassium chloride, trichosanthis, or mifepristone.[ 9] Surgical options; embrace uterine curettage, hysteroscopy resection, laparotomy or laparoscopic resection for patients are wishing to reserve fertility .[10] Selection of mode of termination depends on features like size of pregnancy, the hemodynamic Prominence of the patient, presence or absence of scar rupture, levels of hCG, and craving for upcoming fertility . [11] MTX is an antimetabolite drug used broadly in treatment of ectopic pregnancies. Systemic route is the least invasive management and has been commonly used for stable patients. Fertility preservation and reducing the requirement to surgery are the main advantages of its use. However, its use alone needs an extended time to follow-up both beta-hCG to return to normal and gestational mass to resolve [12] some studies proved that CSP responded well to the single dose of Systemic MTX 50 mg/m2
When HCG level is lower than 5000 mIU/ml. [13] others found that single-dose, systemic MTX was not sufficient, so they had to achieve multiple doses of MTX with its drawbacks. [14] Others found that combination of single dose of systemic Methotrexate followed by D&S can avoid these needless laparotomy and preserve fertility in most women with CSP. [15] our aim of the work, to evaluate the efficacy and safety of single dose of of Systemic MTX 50 mg/m2 followed by D&S in cases of Cesarean scar pregnancy (CSP) .
This is a prospective clinical study was done on 35 pregnant females with a diagnosis of CSP between 6 and 11weeks were admitted to our department from January 2017 to July 2019.
Gestational age was considered built on last menstrual period and accustomed according to the ultrasound dating.They were managed by MTX injection followed by D&S (combined therapy group) .All enrolled Women were hemodynamically stable,, had no internal bleeding, or ruptured CSP, the gestational sac ±8 weeks and had no contraindications to MTX, like elevated liver neutropenia or disturbed renal function tests. The diagnosis of CSP was proved according to the following criteria;
- Positive serum b-hCG levels,
- History of lower uterine segment cesarean delivery
-Gratification of the following ultrasonography conditions;
a) Visualized endometrium with an empty uterine cavity
b) A pure observable empty cervical canal;
C) A gestational sac with or without cardiac activity positioned anteriorly at the level of the the lower uterine segment with cesarean scar,{ internal os } inside a evident myometrial fault between the bladder and the sac on sagittal view of the uterus .
d) Negative ‘‘sliding organs sign,’’ which was demarcated as the failure to dislodge the gestational sac from its place at the level of the internal os using mild pressure smeared by the transvaginal probe.
e) Suggestion of functional placental circulation / trophoblastic on color flow Doppler examination [16] A written informed consent was taken from all participants. Our study was approved by the institutional research ethical committee of zagazig University according the standards of Helsinki Declaration .Full informations and counseling about nature of management and its hazards were given to the patients. All patients were managed by ;50mg of MTX in the form of a single dose Intramuscular injection then cervical dilatation and suction aspiration with a Karman cannula (D&S) under guidance of ultrasound after 48 preceded by vaginal misoprostol 2 tablet (200 mg) 4 hours ago. Positive outcomes were:
● decreasing serum b-hCG levels up to normal level.
● Vanishing CSP mass,
● evading the foremost complications like; rupture of uterine scar, hemorrhage, Conversion to laparoscopic surgery or laparotomy, or hysterectomy.Statistical analyses were done with SPSS for Windows (version 16.0; SPSS, Chicago, IL). Data were analyzed for normal distribution with the Kolmogorov-Smirnov test and for homogeneity of variance with Levene test. The variables did not meet homogeneity of variance and normality and were analyzed using Mann-WhitneyU test.
The demographic criteria of patients were presented in Table 1. Mean age, parity and gravity of patients was (32.1±3.5 years), 2.1±0.5 and 3.4±1.7 respectively. At ultrasound scan, Wholly 35 women had an empty uterine cavity with the gestational placed at the site of scar, nearby the bladder. All women had a history of previous cesarean section .The mean gestational age at diagnosis 8.5±1.6 (wks). The mean Levels of HCG were documented before starting the management 7424±2.560 (mIU/mL). The mean of myometrial thickness between the sac and the bladder wall under ultrasonic investigation was 2.6±0.89 mm.All females had a history of previous uterine surgery. The mean number of previous cesarean sections was 3.6±0.72, from the 35 women, 8(22.5%) had three, 18 (51.4%) had two, 6 (17.1%) had one, 2 (5.7%) had had four and 1 (2.8%) had five CDs.
At the time of diagnosis, 50% of the females were complaining from mild vaginal bleeding, and remaining were diagnosed with routine antenatal ultrasound examination without complaint.
Values are presented as mean ± SD, No. (Percentage %)
Post dilatation and suction (D&S), two cases had plentiful vaginal bleeding which was controlled with a Foley's catheter put intrauterine for 24 hours as a mechanical hemostasis. Three patients need laparotomic hysterotomy two of them can managed by wedge resection of the gestational sac lesion and successful repair of the uterine defect. Only one, had profuse intraoperative bleeding and big defect in the uterus at the scar area, which was cotrolled by urgent subtotal hysterectomy, Salpingectomy, with conservation of the ovaries. No more complications postoperatively were observed either at the 1-week or 1-month follow-up
Systemic administration of MTX is a standard management for tubal and cervical pregnancy (17). In the Current study we found that a single dose of 50 mg IM MTX followed by D&S had a high cure rate , In patients with CSPs . In study of Hua Wang, etal 2008 , who compared the efficacy of methotrexate (MTX) regimen only or MTX regimen followed by dilation
curettage (D&C). in women with cesarean scar pregnancy (CSP) , they found that Both regimens could treat most of CSP patients efficaciously, but the combined one caused a shorter period of treatment and designated a more satisfactory effect.[18] In the current study, 88.6%
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
